The controversial role of metabolic reprogramming in anti-tumor therapy resistance.
Saved in:
| Title: | The controversial role of metabolic reprogramming in anti-tumor therapy resistance. |
|---|---|
| Authors: | Xu Y; Department of Interventional Medicine, The People's Hospital of China Medical University/The People's Hospital of LiaoNing Province, No. 33 Wenyi Road, Shenhe District, Shenyang, China., Wang Y; The Fourth Clinical College, China Medical University, Shenyang, China., Fu Q; Department of Cardiology, The People's Hospital of China Medical University/The People's Hospital of LiaoNing Province, Shenyang, China., Yao Y; Department of Interventional Medicine, The People's Hospital of China Medical University/The People's Hospital of LiaoNing Province, No. 33 Wenyi Road, Shenhe District, Shenyang, China. yaoyuan-621@163.com., Zhou Y; Department of Interventional Medicine, The People's Hospital of China Medical University/The People's Hospital of LiaoNing Province, No. 33 Wenyi Road, Shenhe District, Shenyang, China. zhouyubin2025@126.com. |
| Source: | Discover oncology [Discov Oncol] 2026 Mar 15; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 15. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
